화학공학소재연구정보센터
Macromolecular Research, Vol.20, No.4, 379-384, April, 2012
Synthetic Polymer Membranes as a Proxy of Skins in Permeation Studies of Biologically Active Compounds
E-mail:
This study provides a practical approach that can afford evaluation of drug compound permeability through the skin in which synthetic polymer membranes are used as a proxy. For this, permeation behaviors of a variety of drug molecules through the synthetic membranes were characterized under the iontophoresis condition as well as passive delivery. As a proof of concept, the permeability of caffeine and TriamiondilTM, both of which are model drug compounds, through the membranes correlated with conventional use of porcine skin. The synthetic polymer membranes showed similar drug permeation patterns to that of the porcine skin, which allowed us to apply them to an alternate to the animal skin. Moreover, the application of iontophoresis to the device system enabled the drug molecules to pass through both the polymer membranes and porcine skin. Our study also verified that drug permeation is substantially influenced by the current direction that likely drives either electrorepulsion or electroosmosis under iontophoretic conditions.
  1. de Jager M, Groenink W, van der Spek J, Janmaat C, Gooris G, Ponec M, Bouwstra J, Biochim. Biophys. Acta., 1758, 636 (2006)
  2. Kligman AM, Am. Heart J., 108, 200 (1984)
  3. Sherertz EF, Sloan KB, McTiernan RG, Arch. Dermatol.Res., 282, 463 (1990)
  4. Du Plessis J, Weiner N, Muller D, Int. J. Pharm., 103, 1 (1994)
  5. Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Monkkonen J, Eur. J. Pharm. Sci., 7, 279 (1999)
  6. Arshney M, Thanna T, Changez M, Colloids Surf. B:Biointerfaces., 13, 1 (1999)
  7. Shin J, Shin K, Lee H, Nam JB, Jung JE, Ryu JH, Han JH, Suh KD, Kim YJ, Shim J, Kim J, Han SH, Char K, Kim YK, Chung JH, Lee MJ, Kang BC, Kim JW, Adv. Mater., 22(6), 739 (2010)
  8. Destree C, Ghijsen J, Nagy JB, Langmuir, 23(4), 1965 (2007)
  9. Fan Q, Sirkar KK, Michniak B, J. Membr. Sci., 321(2), 240 (2008)
  10. Benson HAE, McElnay JC, Harlan R, Hadgraft J, Pharm. Res., 8, 204 (1991)
  11. Denet AR, Vanbever R, Preat V, Adv. Drug Deliv. Rev., 56, 659 (2004)
  12. Lupton JR, Williams CM, Alster TS, Dermatol.Surg., 28, 833 (2002)
  13. Bjerring P, Christiansen K, J. Cutan. Laser Ther., 2, 177 (2002)
  14. Yan G, Xu Q, Anissimov YG, Hao J, Higuchi WI, Li SK, Pharm. Res., 25, 616 (2008)
  15. Singh P, Maibach HI, Crit. Rev. Ther. Drug Carrier Syst., 11, 161 (1994)
  16. Oldenburgh KR, Vo K, Smith GA, Selick HE, J.Pharm. Sci., 84, 915 (1995)
  17. Fritz P, Schmook JG, Meingassner AB, Int. J.Pharm., 215, 51 (2001)
  18. Andega S, Kanikkannan N, Singh M, J. Control.Release., 77, 17 (2001)
  19. Mandenius CF, Bjorkman M, Trends Biotechnol., 28, 230 (2010)
  20. de Jager M, Groenink W, Guivernau RB, Andersson E, Angelova N, Ponec M, Bouwstra J, Pharm. Res., 23, 951 (2006)
  21. Wohnsland F, Faller B, J. Med. Chem., 44, 923 (2001)
  22. Rashbass J, Stekel D, Williams ED, J. Pathol., 179, 333 (1996)
  23. Wijmans JG, Baker RW, J. Membr. Sci., 107(1-2), 1 (1995)
  24. Jaskari T, Vuorio M, Kontturi K, Urtti A, Manzanares JA, Hirvonen J, J. Control. Release., 67, 179 (2000)
  25. Ghosh R, J. Membr. Sci., 192(1-2), 145 (2001)
  26. Lee CK, Uchida T, Kitagawa K, Yagi A, Kim NA, Goto S, Biol. Pharm. Bull., 17, 1421 (1994)
  27. Bos JD, Meinardi MM, Exp. Dermatol., 9, 165 (2000)
  28. Yabuki A, Kamimura R, Setoyama K, Tottori J, Taniguchi K, Matsumoto M, Suzuki S, Exp. Anim., 56, 369 (2007)
  29. Pikal MJ, Adv. Drug Deliv. Rev., 46, 281 (2001)
  30. Volpato NM, Santi P, Colombo P, Pharm. Res., 12, 1623 (1995)